Role of perfusion imaging in computed tomography in diagnostics of cerebral gliomas;Rola obrazowania perfuzji w tomografii komputerowej w diagnostyce glejaków ośrodkowego układu nerwowego

Neurologia i Neurochirurgia Polska

Volumn 40, Issue 1, 2006, Pages 51-56

  Dziubińska, Maria ^a   Basiak, Marcin ^a   Konopka, Marek ^a,b   Hartel, Marcin ^a   Pilch Kowalczyk, Joanna ^a,b   Sasiadek, Marek ^c  

^a Helimed Diagnostic Imaging Sp z oo   (Poland)

^b MEDICAL UNIVERSITY OF SILESIA   (Poland)

^c WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

Cerebral gliomas; Perfusion CT; Tumor vascularity

Indexed keywords

ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; BRAIN PERFUSION; CANCER GRADING; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC IMAGING; FUNCTIONAL ASSESSMENT; GLIOMA; HEMODYNAMICS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MEMBRANE PERMEABILITY; NEUROIMAGING; PATIENT MONITORING; PUBLICATION; TREATMENT PLANNING; VASCULARIZATION;

BLOOD VOLUME; BRAIN; BRAIN NEOPLASMS; CEREBROVASCULAR CIRCULATION; GLIOMA; HEMODYNAMIC PROCESSES; HUMANS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 32544458179     PISSN: 00283843     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Roberts H.C., Roberts T.P., Braasch R.C. i wsp. Quantitative measurement of microvascular permeability in human brain tumors achieved using dynamic contrast-enhanced MR imaging: correlation with histologic grade. AJNR Am J Neuroradiol 2000; 21: 891-899.
2. Aronen H.J., Gazit I.E., Louis D.N. i wsp. Cerebral blood volume maps of gliomas: comparison with tumor grade and histologic findings. Radiology 1994; 191: 41-51.
3. Roberts H.C., Roberts T.P., Bollen A.W. i wsp. Correlation of microvascular permeability derived from dynamic contrast-enhanced MR imaging with histologic grade and tumor labeling index: a study in human brain tumors. Acad Radiol 2001; 8: 384-391.
4. Sugahara T., Korogi Y., Tomiguchi S. i wsp. Posttherapeutic intraaxial brain tumor: the value of perfusion-sensitive contrast-enhanced MR imaging for differentiating tumor recurrence from nonneoplastic contrast-enhancing tissue. AJNR Am J Neuroradiol 2000; 21: 901-909.
5. Cenic A., Nabavi D.G., Craen R.A. i wsp. A CT method to measure hemodynamics in brain tumors: validation and application of cerebral blood flow maps. AJNR Am J Neuroradiol 2000; 21: 462-470.
6. Nabavi D.G., Cenic A., Craen R.A. i wsp. CT assessment of cerebral perfusion: experimental validation and initial clinical experience. Radiology 1999; 213: 141-149.
7. Eastwood J.D., Lev M.H., Azhari T. i wsp. CT perfusion scanning with deconvolution analysis: pilot study in patients with acute middle cerebral artery stroke. Radiology 2002; 222: 227-236.
8. Cenic A., Nabavi D.G., Craen R.A. i wsp. Dynamic CT measurement of cerebral blood flow: a validation study. AJNR Am J Neuroradiol 1999; 20: 63-73.
9. Wintermark M., Thiran J.P., Maeder P. i wsp. Simultaneous measurement of regional cerebral blood flow by perfusion CT and stable xenon CT: a validation study. AJNR Am J Neuroradiol 2001; 22: 905-914.
10. Eastwood J.D., Provenzale J.M. Cerebral blood flow, blood volume, and vascular permeability of cerebral glioma assessed with dynamic CT perfusion imaging. Neuroradiol 2003; 45: 373-376.
11. Russel D., Rubinstein L. Tumors of central neuroepithelial origin. W: Rubenstein L.J. (red.). Pathology of tumors of the nervous system. Williams and Wilkins, Baltimore, 1989, ss. 83-350.
12. Glantz M.J., Burger P.C., Herndon J.E. i wsp. Influence of the type of surgery on the histologic diagnosis in patients with anaplastic gliomas. Neurology 1991; 41: 1741-1744.
13. Weidner N., Semple J.P., Welch W.R. i wsp. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991; 324: 1-8.
14. Macchiarini P., Fontanini G., Hardin M.J. i wsp. Relation of neovascularisation to metastasis of non-small-cell lung cancer. Lancet 1992; 340: 145-146.
15. Grond M., von Kummer R., Sobesky J. i wsp. Early x-ray hypoattenuation of brain parenchyma indicates extended critical hypoperfusion in acute stroke. Stroke 2000; 31: 133-139.
16. von Kummer R., Bourquain H., Bastianello S. i wsp. Early prediction of irreversible brain damage after ischemic stroke at CT. Radiology 2001; 219: 95-100.
17. Ueda T., Yuh W.T., Maley J.E. i wsp. Current and future imaging of acute cerebral ischemia: assessment of tissue viability by perfusion imaging. J Comput Assist Tomogr 1999; 23 (supl. 1): S3-S7.
18. Szczudlik A. Parofizjologia udaru niedokrwiennego. W: Prusiński A., Donzal T.M., Kozubski W., Szczudlik A. (red.). Niedokrwienne udary mózgu. Wyd. 1. Alfa-Medica Press, Bielsko-Biała 1999, ss. 58-86.
19. Wintermark M., Thiran J.P., Schnyder P. i wsp. Perfusion CT offers hope in stroke control. Diagnostic imaging Europe 2001; 11: 35-39.
20. Koenig M., Kraus M.,Theek C. i wsp. Quantitative assessment of the ischemic brain by means of perfusion-related parameters derived from perfusion CT. Stroke 2001; 32: 431-437.
21. Aksoy P.G., Lev M.H. Dynamic contrast-enhanced brain perfusion imaging: technique and clinical applications. Semin Ultrasound CT MR 2000; 21: 462-477.
22. Wintermark M., Maeder P., Verdun F.R. i wsp. Using 80 kVp versus 120 kVp in perfusion CT measurement of regional cerebral blood flow. AJNR Am J Neuroradiol 2000; 21: 1881-1884.
23. Pilch-Kowalczyk J., Konopka M., Gibińska J. i wsp. Perfuzja TK - nowa jakość w diagnostyce obrazowej udaru niedokrwiennego. Med Sci Rev 2002; 1: 62-66.
24. Wintermark M., Maeder P., Thiran J.P. i wsp. Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models. Eur Radiol 2001; 11: 1220-1230.
25. Roberts H.C., Roberts T.P., Lee T.Y. i wsp. Dynamic, contrast-enhanced CT of human brain tumors: quantitative assessment of blood volume, blood flow, and microvascular permeability: report of two cases. AJNR Am J Neuroradiol 2002; 23: 828-832.
26. Leenstra S., Troost D., Hulsebos T.J. i wsp. Genetic versus histological grading in stereotactic biopsies. Stereotact Funct Neurosurg 1994; 63: 56-62.
27. Ludemann L., Grieger W., Wurm R. i wsp. Comparison of dynamic contrast-enhanced MRI with WHO tumor grading for gliomas. Eur Radiol 2001; 11: 1231-1241.
28. Lund E.L., Spang-Thomson M., Skovgaard-Poulsen H. i wsp. Tumor angiogenesis - a new therapeutic target in gliomas. Acta Neurol Scand 1998; 97: 52-62.
29. Atherton J.V., Huda W. Energy imparted and effective doses in computed tomography. Med Phys 1996; 23: 735-741.
30. E, in positron emission tomography studies. Eur J Nucl Med 1990; 17: 116-120.
31. 99mTc labelled radiopharmaceuticals. Eur J Nucl Med 1989; 15: 174-179.
32. Johnson D. W., Stringer W.A., Marks M.P i wsp. Stable xenon CT cerebral blood flow imaging: rationale for and role in clinical decision making. AJNR Am J Neuroradiol 1991; 12: 201-213.
33. Kahn D., Follett K.A., Bushnell D.L. i wsp. Diagnosis of recurrent brain tumor: value of 201Tl SPECT vs 18F-fluorodeoxyglucose PET. AJR Am J Roentgenol 1994; 163: 1459-1465.